Simon Yates fails drug test: British cyclist tests positive after 'doctor's error'
Simon Yates’ team Orica-GreenEdge have accepted responsibility for the positive test for Terbutaline, which is used to relieve asthma symptoms
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.British cyclist Simon Yates has tested positive following a doctor's error, his team have announced.
Orica-GreenEdge have accepted responsibility for Yates' positive test for Terbutaline, which is used to relieve asthma symptoms.
The Australian team admitted an administrative error led to the medicine being administered without the required therapeutic user exemption certificate.
A statement from Orica-GreenEdge read: “There has been no wrong-doing on Simon Yates' part.
”The team takes full responsibility for this mistake and wishes to underline their support for Simon during this process.“
The team were made aware of the positive test on April 22, following a test conducted on March 12, at stage six of Paris-Nice. He finished sixth on the stage.
The statement added: “The positive result is for the substance Terbutaline.
“The substance was given to Simon Yates in the form an asthma inhaler and accordingly, this was noted by the team doctor on the doping control form, signed at the time of the test.
“The substance was given in an ongoing treatment of Simon Yates' documented asthma problems. However, in this case the team doctor made an administrative error by failing to apply for the TUE required for the use of this treatment.
“The use of Terbutaline without a current TUE is the reason it has been flagged as an adverse analytical finding.
“This is solely based on a human error that the doctor in question has taken full responsibility for.”
The 23-year-old from Bury, who won gold in the points race at the 2013 Track World Championships in Minsk, is among Britain's brightest prospects.
He made his Tour de France debut in 2014 and raced again in 2015, after opting to sign for Australian squad Orica-GreenEdge ahead of Team Sky.
Yates is the older twin and his brother Adam also races for Orica-GreenEdge and Britain. They are not related to former rider Sean Yates.
Simon Yates finished 2015 as the best young rider in the Criterium du Dauphine and Tour of the Basque Country. He also finished eighth on stage three of the Tour de France, which finished atop the Mur de Huy in Belgium.
Orica-GreenEdge say they are attempting to clarify the situation with the UCI, cycling's world governing body.
“The team is concerned by the leak of this information and has no further comments until there has been a full evaluation made of the documentation, statements and evidence that the team and Simon Yates are now submitting to the UCI in order to clarify everything,” the statement added.
British Cycling, the sport's embattled national governing body, confirmed the positive test.
A British Cycling spokesman said: “British Cycling can confirm that it has been notified by the UCI of a potential anti-doping rule violation against a British rider based on an analysis of a sample provided in-competition.
“As with any other doping violation charge at this level, those proceedings will be managed independently of British Cycling by the UCI.
“It would be inappropriate to comment further until the process has been completed.”
A UK Anti-Doping spokeswoman said: “UK Anti-Doping does not discuss or disclose details of any cases until due legal process has been completed and an anti-doping rule violation is deemed to have been committed. Once the legal process is complete, details of all anti-doping rule violations are published on our website.”
PA
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments